Scope

Auris Nasus Larynx provides the opportunity for rapid, carefully reviewed publications concerning the fundamental and clinical aspects of otorhinolaryngology and related fields. This includes otology, neurotology, bronchoesophagology, laryngology, rhinology, allergology, head and neck medicine and oncologic surgery, maxillofacial and plastic surgery, audiology, speech science and communication disorders.

Types of papers

Original papers, short communications and original case reports can be submitted. Reviews on recent developments are invited regularly and Letters to the Editor commenting on papers or any aspect of the Journal are welcomed.

Original papers should report the results of original research, and the material should not have been previously published elsewhere, except in preliminary form. Manuscripts should be as concise and to the point as possible. Please condense your manuscript as much as possible. It is recommended that papers should in general not exceed 10 printed pages.

Short communications are brief and contain significant new results. Recommended size is a maximum of 4 printed pages (6-8 double-spaced typed pages) including figures and tables. Short Communications should be concisely but adequately referenced.

Case reports should describe truly unique and/or educationally valuable cases, which provide benefits for future patients. Text should be limited to 1800 words (6 double-spaced typewritten pages) including an abstract, with no more than 15 references and a maximum of 4 figures/tables. An abstract for case reports should not exceed 200 words and should not have a structured format.

Online Submission of Manuscripts http://ees.elsevier.com/anl

Submission and peer review of all papers is now conducted entirely online using the dedicated site at http://ees.elsevier.com/anl

Authors are required to register upon using the system for the first time. Authors are guided stepwise through the entire process, and are kept abreast of the progress of their paper at each stage.

The system creates a PDF version of the submitted manuscript for peer review, revision and proofing. All correspondence, including the Editor's decision and request for revisions, is conducted by e-mail.

Further information and support

Authors requesting further information on online submission are strongly encouraged to view an online tutorial, at http://ees.elsevier.com/anl or visit our customer support site at http://support.elsevier.com.

Submission of manuscripts: Originality and copyright

Submission of an article is understood to imply that the article is original and is not being considered for publication elsewhere. Upon acceptance of the article by the journal, the author(s) will be asked to transfer the copyright of the article to the publisher. This transfer will ensure the widest possible dissemination of information.

Multiple authorship

On submission, all authors of the paper listed should sign a letter in which they state that they all have participated sufficiently in the conception and design of the work, in the analysis of the data and in writing the manuscript to take public responsibility for it.

Ethical standards

Human subject experiments or the usage of human materials (such as tissues) should be in accordance with the ethical standards of a responsible committee at the institute where the research is carried out and with the Helsinki Declaration. Animal studies should be carried out within recognised guidelines for the care of laboratoryanimals.

Preparation of manuscripts

Authors are asked to bear in mind the following additional points before entering the submission process.

Ensure that the letter "l" and digit "1" (also letter "O" and digit "0") have been used properly, and structure your article (tabs, indents, etc.) consistently.

Manuscripts should be written in English. Authors whose native language is not English are strongly advised to have their manuscripts checked by an English-speaking colleague prior to submission.

Format and structure

Most text formats can be accommodated, but Microsoft Word is preferable. Manuscripts should in general be divided into the following components: title, authors' names and affiliations, abstract, keywords, text (introduction, materials and methods, results, discussion, conclusion, acknowledgments, conflict of interest), references, tables, figure legends, figures. Number pages consecutively.

The title page should include (1) a concise but informative title, (2) authors' names, affiliations and full postal addresses, (3) name, telephone number and e-mail address of the author handling correspondence and proofs.

Abstract
An abstract of your manuscript summarizing the content, at a maximum of 400 words, should be provided as a separate submission item. It should be informative, not merely descriptive, and it must be composed by four divisions: (1) Objective should concisely describe the hypothesis, problem and/or purpose of the study; (2) Methods should include basic procedures and materials, and observational and analytical methods; (3) Results should describe major findings and statistical significance, if possible by all means; and (4) Conclusion must very clearly and concisely state the principal conclusion(s) of the study. Reviews and Case reports need not follow these instructions. Abstracts for Case reports should not exceed 200 words.

Keywords
3-6 keywords (indexing terms) should be supplied. Full instructions are provided when submitting your article online.

Conflict of interest
A disclosure statement is required for all studies submitted to Auris Nasus Larynx. At the end of text, all authors must disclose any financial and personal relationships with other people or organisations that could influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Example statement: "Conflicts of interest: This study was financially supported by Audion, Inc. and the first author A.S. was a paid consultant to the company from 2001 to 2010." If no conflict exists, explicitly state so; for example: "Conflict of interest: None." See also http://www.elsevier.com/conflictsofinterest.

Figures
Figures of good quality should be submitted online as a separate file. For preparing figure files, please refer to instructions at http://www.elsevier.com/wps/find/authors.authors/authorartworkinstructions. Minimum resolutions for line drawings should be 600 dpi and photographs 300 dpi.

Illustrations should be numbered with Arabic numerals according to their sequence in the text. References should be made in the text to each illustration.

Illustrations should be designed with the format of the page of the journal in mind. Illustrations and lettering should be of such a size as to allow a photographic reduction of 50% without becoming illegible. Explanations should preferably be given in the typewritten legend. Drawn text in the illustrations should be kept to a minimum.

If scales are required, use bar scales on the illustration itself instead of numerical magnification factors.

Each illustration should have a legend. The legends to all illustrations should be typed together on a separate sheet at the end of the manuscript.

Colour illustrations can only be included, if the cost of reproduction is paid for by the author or a sponsor.

Permission to reproduce illustrations should always be obtained before submission and details included with the captions.

For detailed instructions on the preparation of electronic artwork, consult Elsevier's Author Gateway at http://authors.elsevier.com.

Tables

Tables should be submitted online as a separate file, bear a concise title, and be numbered with Arabic numerals. Tables should be cited in the text. Column headings should be brief, but sufficiently explanatory. Standard abbreviations of units of measurement should be added between parentheses. Vertical lines should not be used to separate columns.

References

1. All publications cited in the text should be presented in a list of references following the text of the manuscript. The manuscript should be carefully checked to ensure that the spellings of authors' names are exactly the same in the text and in the list of references. Authors are responsible for the accuracy and completeness of their references and for correct text citation.

2. References should be numbered consecutively in the order in which they are first mentioned. In the text they should be cited with Arabic numerals between square brackets. For listing references, follow the Vancouver style, abbreviating names of journals according to the list in Medline (http://www.nlm.nih.gov/tsd/serials/lji.html). List all authors/editors but if there are more than six, list the first six plus et al.

Examples:

[1] Froehlich P, Seid AB, Morgon A. Contrasting strategic approaches to the management of subglottic hemangiomas. Int J Pediatr Otorhinolaryngol 1996;36:137-46.

[2] Marcus R, Couston AM. Water-soluble vitamins: the vitamin B complex and ascorbic acid. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press; 1990. p. 1530-52.

3. This journal should be cited as Auris Nasus Larynx.

4. Manuscripts accepted for publication not yet published should be referred to as "in press." Manuscripts submitted but not yet accepted should be referred to as "unpublished observation."

Supplementary and Multimedia Data
Elsevier accepts electronic supplementary and multimedia data to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data are provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. Video files: please supply 'stills' with your files: you can choose any frame from the video or make a separate image. These will be used instead of standard icons and will personalize the link to your supplementary information. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.

Proofs

One set of proofs will be sent to the corresponding author as given on the title page of the manuscript. Only typesetters' errors may be corrected; no changes in or additions to, the edited manuscript will be allowed.

Offprints

Fifty offprints or e-offprint (PDF) by choice of each article will be supplied free of charge. Additional offprints can be ordered by the authors. An order form containing price quotations will be sent to the corresponding author.

All questions arising after acceptance of the manuscript, especially those relating to proofs, should be directed to: Editorial Dept., Elsevier Scientific Publishers Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland, Tel: +353-61-709652, Fax: +353-61-709110.

Author rights

As an author you (or your employer or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.

Auris Nasus Larynx has no page charges